Browse by Section 100 Item List

PBS GROWTH HORMONE PROGRAM

The Australian Government provides subsidised access to growth hormone medicines for eligible paediatric and adult patients through the Pharmaceutical Benefits Scheme (PBS) Growth Hormone Program established under section 100 of the National Health Act 1953. Growth Hormone restriction criteria is clinically complex.  Different restriction criteria apply to the writing of a prescription for growth hormone for adults and children respectively. Prescribers should ensure the appropriate restriction criteria are met at the time of prescribing.

On 1 October 2022, two new medicines were listed on the Section 100 Growth Hormone Program – mecasermin and somatrogon. Somatrogon has been listed for the treatment of paediatric patients with (1) short stature associated with biochemical growth hormone deficiency, and (2) short stature and slow growth. Mecasermin has been listed for the long-term treatment of growth failure in children and adolescents from 2 to 18 years with severe primary insulin-like growth factor 1 deficiency (Primary IGFD).

There are a number of prescribers authorised to treat patients for PBS-subsidised treatment with growth hormone medicines. This is dependent upon the appropriate restriction criteria at the time of prescribing. Growth Hormone medicines can be dispensed by a community pharmacy, a participating PBS reform public hospital pharmacy, a private hospital pharmacy and a dispensing doctor.

Prescribers are able to apply to Services Australia for the supply of Growth Hormone. Prescribing information, including Authority Application forms and other relevant documentation (as applicable) are available on the Services Australia website.

On 1 January 2020, changes were made to the Pharmaceutical Benefits Scheme (PBS) restrictions for growth hormone treatment in adults, which set out the eligibility requirements for PBS subsidy, to provide additional clarity and improved access to growth hormone treatment.

On 1 February 2019, revised eligibility restrictions to PBS subsidised paediatric growth hormone treatment took effect. The eligibility restriction changes relate to:

  • revised height percentile thresholds;
  • growth velocity percentile for bone age and sex;
  • clarification of definitions within the restrictions; and
  • streamlining the way associated growth data requirements are specified within the prescriber instructions.
  • Legend
  • MPMedical Practitioner
  • SO
    Products that are in a Supply Only state will be available for dispensing, but not for prescribing. PBS Prescriptions written prior to the Supply Only period are able to be dispensed using either the Supply Only product where available, or an equivalent product as specified on the PBS schedule.
    Supply Only
Prescriber code Item code Name, manner of administration and form & strength Max qty
packs
Max qty
units
No. of
repeats
MP 13116H MECASERMINmecasermin 10 mg/mL injection, 4 mL vial 1 1 5
MP 13119L SOMATROGONsomatrogon 24 mg/1.2 mL injection, 1.2 mL pen device 1 1 1
MP 13130C SOMATROGONsomatrogon 24 mg/1.2 mL injection, 1.2 mL pen device 1 1 1
MP 13120M SOMATROGONsomatrogon 60 mg/1.2 mL injection, 1.2 mL pen device 1 1 1
MP 13125T SOMATROGONsomatrogon 60 mg/1.2 mL injection, 1.2 mL pen device 1 1 1
MP 10438J SOMATROPINsomatropin 10 mg/2 mL injection, 2 mL cartridge 1 1 1
MP 10478L SOMATROPINsomatropin 10 mg/2 mL injection, 2 mL cartridge 1 1 1
MP 11650E SOMATROPINsomatropin 10 mg/2 mL injection, 2 mL cartridge 1 1 5
MP 9604L SOMATROPINsomatropin 10 mg/2 mL injection, 2 mL cartridge 1 1 1
MP 10426R SOMATROPINsomatropin 12 mg injection [1 chamber] (&) inert substance diluent [1 mL chamber], 1 dual chamber pen device 1 1 1
MP 10431B SOMATROPINsomatropin 12 mg injection [1 chamber] (&) inert substance diluent [1 mL chamber], 1 dual chamber pen device 1 1 1
MP 11495B SOMATROPINsomatropin 12 mg injection [1 chamber] (&) inert substance diluent [1 mL chamber], 1 dual chamber pen device 1 1 5
MP 9586M SOMATROPINsomatropin 12 mg injection [1 chamber] (&) inert substance diluent [1 mL chamber], 1 dual chamber pen device 1 1 1
MP 10435F SOMATROPINsomatropin 5 mg injection [1 chamber] (&) inert substance diluent [1 mL chamber], 1 dual chamber pen device 1 1 1
MP 10443P SOMATROPINsomatropin 5 mg injection [1 chamber] (&) inert substance diluent [1 mL chamber], 1 dual chamber pen device 1 1 1
MP 11493X SOMATROPINsomatropin 5 mg injection [1 chamber] (&) inert substance diluent [1 mL chamber], 1 dual chamber pen device 1 1 5
MP 9585L SOMATROPINsomatropin 5 mg injection [1 chamber] (&) inert substance diluent [1 mL chamber], 1 dual chamber pen device 1 1 1
MP 10441M SOMATROPINsomatropin 10 mg/1.5 mL injection, 1.5 mL cartridge 1 1 1
MP 10451C SOMATROPINsomatropin 10 mg/1.5 mL injection, 1.5 mL cartridge 1 1 1
MP 10481P SOMATROPINsomatropin 10 mg/1.5 mL injection, 1.5 mL cartridge 1 1 1
MP 10496K SOMATROPINsomatropin 10 mg/1.5 mL injection, 1.5 mL cartridge 1 1 1
MP 10506Y SOMATROPINsomatropin 10 mg/1.5 mL injection, 1.5 mL cartridge 1 1 1
MP 10514J SOMATROPINsomatropin 10 mg/1.5 mL injection, 1.5 mL cartridge 1 1 1
MP 10519P SOMATROPINsomatropin 10 mg/1.5 mL injection, 1.5 mL cartridge 1 1 1
MP 5819G SOMATROPINsomatropin 10 mg/1.5 mL injection, 1.5 mL cartridge 1 1 1
MP 6311E SOMATROPINsomatropin 10 mg/1.5 mL injection, 1.5 mL cartridge 1 1 1
MP 10483R SOMATROPINsomatropin 12 mg/1.5 mL injection, 1.5 mL cartridge 1 1 1
MP 10495J SOMATROPINsomatropin 12 mg/1.5 mL injection, 1.5 mL cartridge 1 1 1
MP 13709M SOMATROPINsomatropin 12 mg/1.5 mL injection, 1.5 mL cartridge 1 1 5
MP 5824M SOMATROPINsomatropin 12 mg/1.5 mL injection, 1.5 mL cartridge 1 1 1
MP 10446T SOMATROPINsomatropin 15 mg/1.5 mL injection, 1.5 mL cartridge 1 1 1
MP 10449Y SOMATROPINsomatropin 15 mg/1.5 mL injection, 1.5 mL cartridge 1 1 1
MP 10485W SOMATROPINsomatropin 15 mg/1.5 mL injection, 1.5 mL cartridge 1 1 1
MP 10489C SOMATROPINsomatropin 15 mg/1.5 mL injection, 1.5 mL cartridge 1 1 1
MP 10490D SOMATROPINsomatropin 15 mg/1.5 mL injection, 1.5 mL cartridge 1 1 1
MP 5820H SOMATROPINsomatropin 15 mg/1.5 mL injection, 1.5 mL cartridge 1 1 1
MP 10442N SOMATROPINsomatropin 20 mg/2.5 mL injection, 2.5 mL cartridge 1 1 1
MP 10497L SOMATROPINsomatropin 20 mg/2.5 mL injection, 2.5 mL cartridge 1 1 1
MP 3388H SOMATROPINsomatropin 20 mg/2.5 mL injection, 2.5 mL cartridge 1 1 1
MP 10427T SOMATROPINsomatropin 5 mg/1.5 mL injection, 1.5 mL cartridge 1 1 1
MP 10432C SOMATROPINsomatropin 5 mg/1.5 mL injection, 1.5 mL cartridge 1 1 1
MP 10467X SOMATROPINsomatropin 5 mg/1.5 mL injection, 1.5 mL cartridge 1 1 1
MP 10484T SOMATROPINsomatropin 5 mg/1.5 mL injection, 1.5 mL cartridge 1 1 1
MP 10507B SOMATROPINsomatropin 5 mg/1.5 mL injection, 1.5 mL cartridge 1 1 1
MP 10512G SOMATROPINsomatropin 5 mg/1.5 mL injection, 1.5 mL cartridge 1 1 1
MP 10518N SOMATROPINsomatropin 5 mg/1.5 mL injection, 1.5 mL cartridge 1 1 1
MP 11895C SOMATROPINsomatropin 5 mg/1.5 mL injection, 1.5 mL cartridge 1 1 5
MP 5818F SOMATROPINsomatropin 5 mg/1.5 mL injection, 1.5 mL cartridge 1 1 1
MP 6476W SOMATROPINsomatropin 5 mg/1.5 mL injection, 1.5 mL cartridge 1 1 1
MP 10458K SOMATROPINsomatropin 6 mg/1.03 mL injection, 1.03 mL cartridge 1 1 1
MP 10462P SOMATROPINsomatropin 6 mg/1.03 mL injection, 1.03 mL cartridge 1 1 1
MP 13712Q SOMATROPINsomatropin 6 mg/1.03 mL injection, 1.03 mL cartridge 1 1 5
MP 5822K SOMATROPINsomatropin 6 mg/1.03 mL injection, 1.03 mL cartridge 1 1 1
MP 10891F SOMATROPINsomatropin 400 microgram injection [1 chamber] (&) inert substance diluent [0.25 mL chamber], 7 dual chamber syringes 1 7 1
MP 10902T SOMATROPINsomatropin 400 microgram injection [1 chamber] (&) inert substance diluent [0.25 mL chamber], 7 dual chamber syringes 1 7 1
MP 10908D SOMATROPINsomatropin 400 microgram injection [1 chamber] (&) inert substance diluent [0.25 mL chamber], 7 dual chamber syringes 1 7 1
MP 10456H SOMATROPINsomatropin 600 microgram injection [1 chamber] (&) inert substance diluent [0.25 mL chamber], 7 dual chamber syringes 1 7 1
MP 10477K SOMATROPINsomatropin 600 microgram injection [1 chamber] (&) inert substance diluent [0.25 mL chamber], 7 dual chamber syringes 1 7 1
MP 9628R SOMATROPINsomatropin 600 microgram injection [1 chamber] (&) inert substance diluent [0.25 mL chamber], 7 dual chamber syringes 1 7 1
MP 10463Q SOMATROPINsomatropin 800 microgram injection [1 chamber] (&) inert substance diluent [0.25 mL chamber], 7 dual chamber syringes 1 7 1
MP 10479M SOMATROPINsomatropin 800 microgram injection [1 chamber] (&) inert substance diluent [0.25 mL chamber], 7 dual chamber syringes 1 7 1
MP 6313G SOMATROPINsomatropin 800 microgram injection [1 chamber] (&) inert substance diluent [0.25 mL chamber], 7 dual chamber syringes 1 7 1
MP 10430Y SOMATROPINsomatropin 1 mg injection [1 chamber] (&) inert substance diluent [0.25 mL chamber], 7 dual chamber syringes 1 7 1
MP 10480N SOMATROPINsomatropin 1 mg injection [1 chamber] (&) inert substance diluent [0.25 mL chamber], 7 dual chamber syringes 1 7 1
MP 6314H SOMATROPINsomatropin 1 mg injection [1 chamber] (&) inert substance diluent [0.25 mL chamber], 7 dual chamber syringes 1 7 1
MP 10453E SOMATROPINsomatropin 1.2 mg injection [1 chamber] (&) inert substance diluent [0.25 mL chamber], 7 dual chamber syringes 1 7 1
MP 10457J SOMATROPINsomatropin 1.2 mg injection [1 chamber] (&) inert substance diluent [0.25 mL chamber], 7 dual chamber syringes 1 7 1
MP 6315J SOMATROPINsomatropin 1.2 mg injection [1 chamber] (&) inert substance diluent [0.25 mL chamber], 7 dual chamber syringes 1 7 1
MP 10434E SOMATROPINsomatropin 1.4 mg injection [1 chamber] (&) inert substance diluent [0.25 mL chamber], 7 dual chamber syringes 1 7 1
MP 10488B SOMATROPINsomatropin 1.4 mg injection [1 chamber] (&) inert substance diluent [0.25 mL chamber], 7 dual chamber syringes 1 7 1
MP 6316K SOMATROPINsomatropin 1.4 mg injection [1 chamber] (&) inert substance diluent [0.25 mL chamber], 7 dual chamber syringes 1 7 1
MP 10454F SOMATROPINsomatropin 1.6 mg injection [1 chamber] (&) inert substance diluent [0.25 mL chamber], 7 dual chamber syringes 1 7 1
MP 10498M SOMATROPINsomatropin 1.6 mg injection [1 chamber] (&) inert substance diluent [0.25 mL chamber], 7 dual chamber syringes 1 7 1
MP 6317L SOMATROPINsomatropin 1.6 mg injection [1 chamber] (&) inert substance diluent [0.25 mL chamber], 7 dual chamber syringes 1 7 1
MP 10500P SOMATROPINsomatropin 1.8 mg injection [1 chamber] (&) inert substance diluent [0.25 mL chamber], 7 dual chamber syringes 1 7 1
MP 10501Q SOMATROPINsomatropin 1.8 mg injection [1 chamber] (&) inert substance diluent [0.25 mL chamber], 7 dual chamber syringes 1 7 1
MP 6318M SOMATROPINsomatropin 1.8 mg injection [1 chamber] (&) inert substance diluent [0.25 mL chamber], 7 dual chamber syringes 1 7 1
MP 10428W SOMATROPINsomatropin 2 mg injection [1 chamber] (&) inert substance diluent [0.25 mL chamber], 7 dual chamber syringes 1 7 1
MP 10472E SOMATROPINsomatropin 2 mg injection [1 chamber] (&) inert substance diluent [0.25 mL chamber], 7 dual chamber syringes 1 7 1
MP 6319N SOMATROPINsomatropin 2 mg injection [1 chamber] (&) inert substance diluent [0.25 mL chamber], 7 dual chamber syringes 1 7 1